Literature DB >> 23420095

Efficacy of a high FFP:PRBC transfusion ratio on the survival of severely injured patients: a retrospective study in a single tertiary emergency center in Japan.

Daisuke Kudo1, Junichi Sasaki, Satoshi Akaishi, Satoshi Yamanouchi, Tomoaki Koakutsu, Tomoyuki Endo, Takeaki Sato, Ryosuke Nomura, Hironao Yuzawa, Michio Kobayashi, Yotaro Shinozawa, Shigeki Kushimoto.   

Abstract

PURPOSE: Recent studies have shown increased survival benefits when a high fresh frozen plasma (FFP) to packed red blood cell (PRBC) ratio is used during trauma resuscitation. However, some reports have raised questions about the effect of higher FFP:PRBC transfusion ratios. The aim of this study was to examine the efficacy of high FFP:PRBC ratios in injured patients with regard to survival and morbidity in a single tertiary emergency center in Japan.
METHODS: This study examined severe trauma patients who received 10 or more PRBC units during the first 24 h of admission. We examined the relationship between the FFP:PRBC ratios during the first 6 h and the patient outcome.
RESULTS: The severity was similar among all groups. The mortality rate was 44.4% in the high (>1:1.5), 16.7% in the middle (1:1.5-1:2) and 33.3% in the low (<1:2) F:P ratio groups. Only one patient in the high group developed sepsis, and none of the patients developed ARDS.
CONCLUSIONS: The current results indicate that the FFP:PRBC ratios during the first 6 h after admission might not affect the mortality or morbidity. However, differences between trauma care systems in Japan and other countries, along with other study limitations, necessitate that a subsequent prospective multicenter study be undertaken before any definitive conclusions can be made.

Entities:  

Mesh:

Year:  2013        PMID: 23420095     DOI: 10.1007/s00595-013-0518-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  51 in total

1.  Use of recombinant factor VIIa in US military casualties for a five-year period.

Authors:  Charles E Wade; Brian J Eastridge; John A Jones; Susan A West; Philip C Spinella; Jeremy G Perkins; Michael A Dubick; Lorne H Blackbourne; John B Holcomb
Journal:  J Trauma       Date:  2010-08

2.  Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma.

Authors:  John R Hess; John B Holcomb; David B Hoyt
Journal:  Transfusion       Date:  2006-05       Impact factor: 3.157

3.  'Blind' transfusion of blood products in exsanguinating trauma patients.

Authors:  L M G Geeraedts; H Demiral; N P Schaap; P W Kamphuisen; J C Pompe; J P M Frölke
Journal:  Resuscitation       Date:  2007-02-09       Impact factor: 5.262

Review 4.  Trauma critical care.

Authors:  L M Gentilello; D J Pierson
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

5.  Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients.

Authors:  Hasrat Khan; Jon Belsher; Murat Yilmaz; Bekele Afessa; Jeffrey L Winters; S Breanndan Moore; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

Review 6.  Risks of fresh frozen plasma and platelets.

Authors:  Sheila MacLennan; Lorna M Williamson
Journal:  J Trauma       Date:  2006-06

7.  Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients.

Authors:  Kenji Inaba; Bernardino C Branco; Peter Rhee; John B Holcomb; Lorne H Blackbourne; Ira Shulman; Janice Nelson; Demetrios Demetriades
Journal:  Arch Surg       Date:  2010-09

Review 8.  Are we giving enough coagulation factors during major trauma resuscitation?

Authors:  Anthony M-H Ho; Manoj K Karmakar; Peter W Dion
Journal:  Am J Surg       Date:  2005-09       Impact factor: 2.565

9.  The relationship of blood product ratio to mortality: survival benefit or survival bias?

Authors:  Christopher W Snyder; Jordan A Weinberg; Gerald McGwin; Sherry M Melton; Richard L George; Donald A Reiff; James M Cross; Jennifer Hubbard-Brown; Loring W Rue; Jeffrey D Kerby
Journal:  J Trauma       Date:  2009-02

10.  Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation.

Authors:  Asher Hirshberg; Mark Dugas; Eugenio I Banez; Bradford G Scott; Matthew J Wall; Kenneth L Mattox
Journal:  J Trauma       Date:  2003-03
View more
  5 in total

1.  Trauma resuscitation requiring massive transfusion: a descriptive analysis of the role of ratio and time.

Authors:  Ruben Peralta; Adarsh Vijay; Ayman El-Menyar; Rafael Consunji; Husham Abdelrahman; Ashok Parchani; Ibrahim Afifi; Ahmad Zarour; Hassan Al-Thani; Rifat Latifi
Journal:  World J Emerg Surg       Date:  2015-08-14       Impact factor: 5.469

2.  Impact of urgent resuscitative surgery for life-threatening torso trauma.

Authors:  Hisashi Matsumoto; Yoshiaki Hara; Takanori Yagi; Nobuyuki Saito; Kazuki Mashiko; Hiroaki Iida; Tomokazu Motomura; Fumihiko Nakayama; Kazuhiro Okada; Hiroshi Yasumatsu; Taigo Sakamoto; Takao Seo; Yusuke Konda; You Hattori; Hiroyuki Yokota
Journal:  Surg Today       Date:  2016-11-25       Impact factor: 2.549

3.  Association of Early, High Plasma-to-Red Blood Cell Transfusion Ratio With Mortality in Adults With Severe Bleeding After Trauma.

Authors:  Florian Roquet; Arthur Neuschwander; Sophie Hamada; Gersende Favé; Arnaud Follin; David Marrache; Bernard Cholley; Romain Pirracchio
Journal:  JAMA Netw Open       Date:  2019-09-04

4.  Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta-analyses.

Authors:  Luis Teodoro da Luz; Prakesh S Shah; Rachel Strauss; Ayman Abdelhady Mohammed; Pablo Perez D'Empaire; Homer Tien; Avery B Nathens; Barto Nascimento
Journal:  Transfusion       Date:  2019-10-15       Impact factor: 3.157

5.  Fibrinogen and base excess levels as predictive markers of the need for massive blood transfusion after blunt trauma.

Authors:  Takehiro Umemura; Yoshihiko Nakamura; Takeshi Nishida; Kota Hoshino; Hiroyasu Ishikura
Journal:  Surg Today       Date:  2015-11-03       Impact factor: 2.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.